Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial.

Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial.

Item
http://www.wikidata.org/entity/Q30807010
Proteomics in Rheumatoid Arthritis ResearchSolving the puzzle of autoimmunity: critical questionsIndependent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory StudyPre-silencing of genes involved in the electron transport chain (ETC) pathway is associated with responsiveness to abatacept in rheumatoid arthritis.Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis.¹H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis.Rituximab Downregulates Gene Expression Associated with Cell Proliferation, Survival, and Proteolysis in the Peripheral Blood from Rheumatoid Arthritis Patients: A Link between High Baseline Autophagy-Related ULK1 Expression and Improved Pain ControMolecular diagnosis: Implications for ophthalmology.The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytesSerum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis.Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?Increased baseline RUNX2, caspase 3 and p21 gene expressions in the peripheral blood of disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients are associated with improved clinical response to methotrexate therapy.Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.Transcriptome analysis of peripheral blood from patients with rheumatoid arthritis: a systematic review
P2860

Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial.

Item
http://www.wikidata.org/entity/Q30807010
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Use of whole-blood transcripto ...... controlled, open-label trial.
@ast
Use of whole-blood transcripto ...... controlled, open-label trial.
@en
type
label
Use of whole-blood transcripto ...... controlled, open-label trial.
@ast
Use of whole-blood transcripto ...... controlled, open-label trial.
@en
prefLabel
Use of whole-blood transcripto ...... controlled, open-label trial.
@ast
Use of whole-blood transcripto ...... controlled, open-label trial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Use of whole-blood transcripto ...... controlled, open-label trial.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921